|
|
||||||||
ligands modulate effects of
LPS in stimulated rat synovial fibroblasts
1 Laboratoire de Pharmacologie, Unite Mixte de Recherche Centre National de la Recherche Scientifique 7561, 54505 Vandoeuvre-lès-Nancy; and 2 Laboratoire de Biologie du Développement, Unite propre de l'enseignement superieur 2402, 54500 Vandoeuvre-lès-Nancy, France
This work demonstrated the constitutive expression
of peroxisome proliferator-activated receptor (PPAR)-
and PPAR-
in rat synovial fibroblasts at both mRNA and protein levels. A decrease in PPAR-
expression induced by 10 µg/ml lipopolysaccharide (LPS) was observed, whereas PPAR-
mRNA expression was not modified. 15-Deoxy-
12,14-prostaglandin J2
(15d-PGJ2) dose-dependently decreased LPS-induced cyclooxygenase (COX)-2 (
80%) and inducible nitric oxide synthase (iNOS) mRNA expression (
80%), whereas troglitazone (10 µM) only inhibited iNOS mRNA expression (
50%). 15d-PGJ2 decreased
LPS-induced interleukin (IL)-1
(
25%) and tumor necrosis factor
(TNF)-
(
40%) expression. Interestingly, troglitazone strongly
decreased TNF-
expression (
50%) but had no significant effect on
IL-1
expression. 15d-PGJ2 was able to inhibit
DNA-binding activity of both nuclear factor (NF)-
B and AP-1.
Troglitazone had no effect on NF-
B activation and was shown to
increase LPS-induced AP-1 activation. 15d-PGJ2 and
troglitazone modulated the expression of LPS-induced iNOS, COX-2, and
proinflammatory cytokines differently. Indeed, troglitazone seems to
specifically target TNF-
and iNOS pathways. These results offer new
insights in regard to the anti-inflammatory potential of the PPAR-
ligands and underline different mechanisms of action of
15d-PGJ2 and troglitazone in synovial fibroblasts.
peroxisome proliferator-activated receptor-
ligands; rat
synovial fibroblasts; proinflammatory cytokines
This article has been cited by other articles:
![]() |
E.-H. Kim, H.-K. Na, D.-H. Kim, S.-A. Park, H.-N. Kim, N.-Y. Song, and Y.-J. Surh 15-Deoxy-{Delta}12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS Carcinogenesis, April 1, 2008; 29(4): 688 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Rehan, S. K. Dargan-Batra, Y. Wang, L. Cerny, R. Sakurai, J. Santos, R. Beloosesky, D. Gayle, and J. S. Torday A paradoxical temporal response of the PTHrP/PPAR{gamma} signaling pathway to lipopolysaccharide in an in vitro model of the developing rat lung Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L182 - L190. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jaradat, C. Stapleton, S. L. Tilley, D. Dixon, C. J. Erikson, J. G. McCaskill, H. S. Kang, M. Angers, G. Liao, J. Collins, et al. Modulatory Role for Retinoid-related Orphan Receptor {alpha} in Allergen-induced Lung Inflammation Am. J. Respir. Crit. Care Med., December 15, 2006; 174(12): 1299 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Stapleton, M. Jaradat, D. Dixon, H. S. Kang, S.-C. Kim, G. Liao, M. A. Carey, J. Cristiano, M. P. Moorman, and A. M. Jetten Enhanced susceptibility of staggerer (ROR{alpha}sg/sg) mice to lipopolysaccharide-induced lung inflammation Am J Physiol Lung Cell Mol Physiol, July 1, 2005; 289(1): L144 - L152. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hwang, D. J. Kleinhenz, B. Lassegue, K. K. Griendling, S. Dikalov, and C. M. Hart Peroxisome proliferator-activated receptor-{gamma} ligands regulate endothelial membrane superoxide production Am J Physiol Cell Physiol, April 1, 2005; 288(4): C899 - C905. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |